Structured evidence table for Ginkgo Focus Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Ginkgo Focus Meta-Analysis | Efficacy of plant extracts in heart failure patients: a systematic review and network meta-analysis. | 1 | Tang T (2026) | Efficacy of plant extracts in heart failure patients: a systematic review and network meta-analysis. |
| Ginkgo Focus Meta-Analysis | In addition, an overview of systematic reviews synthesized the broader EGb 761 evidence base across indications and highlighted that conclusions require caution given the methodological limitations of many reviews []. | 3 | Yang YoungSoon (2026) | Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope? |
| Ginkgo Focus Meta-Analysis | Real-world observational analyses have also reported associations between prescriptions of Ginkgo leaf extract and reduced risk of dementia severity progression, albeit with the inherent limitations of non-randomized designs []. | 3 | Yang YoungSoon (2026) | Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope? |
| Ginkgo Focus Meta-Analysis | Accordingly, this review revisits the historical evidence base with explicit attention to heterogeneity and methodological design, and then examines biomarker-confirmed AD-spectrum studies as a potential pivot point. | 3 | Yang YoungSoon (2026) | Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope? |
| Ginkgo Focus Meta-Analysis | 1 2 Alzheimer’s disease (AD) remains the most common cause of dementia and continues to impose a major burden on patients, caregivers, and healthcare systems []. | 3 | Yang YoungSoon (2026) | Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope? |
Source documents